期刊文献+

生物可降解纳米粒在经皮和黏膜给药中的研究进展

Progress of biodegradable nanoparticle in transdermal and transmucosal drug delivery
原文传递
导出
摘要 经皮和黏膜给药是一种重要的给药途径,生物可降解纳米粒因其良好的生物可降解性、生物相容性和特殊的通透性而在该给药途径中有着良好的应用前景。目前,研究较多的有聚乳酸共聚乙醇酸、聚己内酯、壳聚糖、共聚物聚乳酸-聚乙烯乙二醇等,主要用于疫苗、基因及蛋白类药物的载体。 Transdermal and transmucosal drug delivery is an important way of delivering drugs. Biodegradable nanoparticle has shown great prospects of application in the field due to its better biodegradability, biocompatibility and particular permeability. Presently, researches are mainly focused on poly (DL-lactide-co-glycolide), polycaprolactone, chitosan and copolymer poly lactic acid-poly ethylene glycol(PLA-PEG), which are mainly used as vehicles for vaccine, gene and protein drugs.
出处 《国际生物医学工程杂志》 CAS 2008年第1期59-62,共4页 International Journal of Biomedical Engineering
基金 上海市科委基金资助项目(054119527)
关键词 生物可降解 纳米粒 经皮和黏膜给药 Biodegradable Nanoparticle Transdermal and transmucosal drug delivery
  • 相关文献

参考文献18

  • 1Carcaboso AM, Hernandez RM, Igartua M, et al. Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PL- GA microparticles [J ]. Vaccine, 2004, 22(11-12): 1423-1432.
  • 2Byrd W, Cassels FJ. The encapsulation of entemtoxigenic Escherichia coli colonization factor CS3 in biodegradable microspheres enhances the murine antibody response following intranasal administration [J].Microbiology, 2006, 152(3): 779-786.
  • 3Byrd W, Cassels FJ. Intranasal immunization of BALB/c mice with enterotoxigenic Escherichia coli colonization factor CS6 encapsulated in biodegradable poly(DL-lactide-co-glycolide) microspheres[J]. Vaccine, 2006, 24(9): 1359-1366.
  • 4Csaba N, Sanchez A, Alonso MJ. PLGA: poloxamer and PLGA: poloxamine blend nanostructures as carriers for nasal gene delivery[J]. J Control Release, 2006, 113(2): 164-172.
  • 5Rohner D, Hutmacher DW, See P, et al. Individually CAD-CAM technique designed, bioresorbable 3-dimensional polycaprolactone framework for experimental reconstruction of craniofacial defects in the pig[J]. Mund Kiefer Gesichtschir, 2002, 6(3): 162-167.
  • 6Singh J, Pandit S, Bramwell VW, et al. Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems[J]. Methods, 2006, 38(2): 96-105.
  • 7Cui Zheng-rong, Mumper RJ. Chitosan-based nanoparticles for topical genetic immunization [J]. J Control Release, 2001, 75(3): 409-419.
  • 8Xu Wei, Shen Yan, Jiang Zheng-gang, et al. Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection[ J]. Vaccine, 2004, 22(27-28): 3603-3612.
  • 9McNeela EA, O'Connor D, Jabbal-Gill I, et al. A mucoaal vaccine against diphtheria: formulation of cross reacting material(CRM (197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery [ J ]. Vaccine, 2000, 19(9-10): 1188-1198.
  • 10Vila A, Sanchez A, Janes K, et al. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice [J]. Eur J Pharm Biopharm, 2004, 57(1): 123-131.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部